Population-based outcomes in large b-cell lymphona by WHO subtype: findings from the UK's haematological malignancy research network

R. Patmore, A. Smith, S. Barrans, D. Painter, D. Howell, C. Burton, E. Roman

Research output: Contribution to journalMeeting abstractpeer-review


Introduction: Distinct morphologic, molecular and immunophenotypic variants of large B-cell lymphoma are well recognised, but information on their outcomes in the general (non-trial) patient populations is scarce. With centralised diagnostics at HMDS, Leeds and a unified clinical network covering a catchment population of ~4 million, the UK's population-based Haematological Malignancy Research Network (www.hmrn.org) was established to provide timely real-world data to answer such questions; and the findings are reported here.
Original languageEnglish
Pages (from-to)196-197
Number of pages2
JournalHematological Oncology
Issue numberS2
Publication statusPublished - 12 Jun 2019
Event15th International Conference on Malignant Lymphoma - Palazzo dei COngressi, Lugano, Switzerland
Duration: 18 Jun 201922 Jun 2019

Cite this